Ulinastatin protects pulmonary tissues from lipopolysaccharideinduced injury as an immunomodulator

Journal of Trauma and Acute Care Surgery

Volumn 72, Issue 1, 2012, Pages 169-176

  Gao, Chengjin ^a   Li, Rongrong ^b   Wang, Sheng ^a  

^a TONGJI UNIVERSITY SCHOOL OF MEDICINE   (China)

^b SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Immunomodulator; Pulmonary injury; Sepsis; Ulinastatin

Indexed keywords

B7 ANTIGEN; CD40 ANTIGEN; CD86 ANTIGEN; CELL ADHESION MOLECULE; HLA DR ANTIGEN; LIPOPOLYSACCHARIDE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MYELOID DIFFERENTIATION FACTOR 88; SELECTIN; TOLL LIKE RECEPTOR 4; ULINASTATIN; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; GLYCOPROTEIN; IMMUNOSUPPRESSIVE AGENT; MYD88 PROTEIN, MOUSE; PADGEM PROTEIN; TLR4 PROTEIN, MOUSE; VASCULAR CELL ADHESION MOLECULE 1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIGEN DETECTION; CONFERENCE PAPER; CONTROLLED STUDY; DENDRITIC CELL; FEMALE; IMMUNOHISTOCHEMISTRY; IMMUNOREGULATION; LUNG ALVEOLUS WALL; LUNG INJURY; LUNG PARENCHYMA; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TISSUE INJURY; ACUTE LUNG INJURY; ANIMAL; ARTICLE; C57BL MOUSE; CHEMICALLY INDUCED DISORDER; DRUG EFFECT; IMMUNOLOGY; INFLAMMATION; LUNG; LUNG ALVEOLUS; METABOLISM; WESTERN BLOTTING;

ACUTE LUNG INJURY; ANIMALS; BLOTTING, WESTERN; DENDRITIC CELLS; E-SELECTIN; FEMALE; GLYCOPROTEINS; IMMUNOSUPPRESSIVE AGENTS; INFLAMMATION; LIPOPOLYSACCHARIDES; LUNG; MICE; MICE, INBRED C57BL; MYELOID DIFFERENTIATION FACTOR 88; P-SELECTIN; PULMONARY ALVEOLI; TOLL-LIKE RECEPTOR 4; VASCULAR CELL ADHESION MOLECULE-1;

EID: 84859651122     PISSN: 21630755     EISSN: 21630763     Source Type: Journal    
DOI: 10.1097/TA.0b013e318223c20f     Document Type: Conference Paper

References (28)

1. von Schlieffen E, Oskolkova OV, Schabbauer G, et al. Multi-hit inhibition of circulating and cell-associated components of the toll-like receptor 4 pathway by oxidized phospholipids. Arterioscler Thromb Vasc Biol. 2009;29:356-362.
2. Fang J, Fang D, Silver PB, et al. The role of TLR2, TRL3, TRL4, and TRL9 signaling in the pathogenesis of autoimmune disease in a retinal autoimmunity model. Invest Ophthalmol Vis Sci. 2010;51:3092-3099.
3. Anas AA, Wiersinga WJ, de Vos AF, van der Poll T. Recent insights into the pathogenesis of bacterial sepsis. Neth J Med. 2010;68:147-152.
4. Johnson GB, Brunn GJ, Platt JL. Cutting edge: an endogenous pathway to systemic inflammatory response syndrome (SIRS)-like reactions through Toll-like receptor 4. J Immunol. 2004;172:20-24.
5. Couper KN, Barnes T, Hafalla JC, et al. Parasite-derived plasma microparticles contribute significantly to malaria infection-induced inflammation through potent macrophage stimulation. PLoS Pathog. 2010;6: e1000744.
6. Cho JS, Kim YC, Morrison SL. Inhibitors of MyD88-dependent proinflammatory cytokine production identified utilizing a novel RNA interference screening approach. PLoS One. 2009;4:e7029.
7. Mogensen TH. Pathogen recognition and inflammatory signaling in innate immune defenses. Clin Microbiol Rev. 2009;22:240-273, Table of Contents.
8. Zhang G, Han J, Welch EJ, et al. Lipopolysaccharide stimulates platelet secretion and potentiates platelet aggregation via TLR4/MyD88 and the cGMP-dependent protein kinase pathway. J Immunol. 2009;182:7997-8004.
9. Dai P, Jeong SY, Yu Y, et al. Modulation of TLR signaling by multiple MyD88-interacting partners including leucine-rich repeat Fli-I-interacting proteins. J Immunol. 2009;182:3450-3460.
10. Bromke BJ, Kueppers F. The major urinary protease inhibitor: simplified purification and characterization. Biochem Med. 1982;27:56-67.
11. Hirose J, Ozawa T, Miura T, et al. Human neutrophil elastase degrades inter-alpha-trypsin inhibitor to liberate urinary trypsin inhibitor related proteins. Biol Pharm Bull. 1998;21:651-656.
12. Umeadi C, Kandeel F, Al-Abdullah IH. Ulinastatin is a novel protease inhibitor and neutral protease activator. Transplant Proc. 2008;40:387-389.
13. Pugia MJ, Lott JA. Pathophysiology and diagnostic value of urinary trypsin inhibitors. Clin Chem Lab Med. 2005;43:1-16.
14. Tsujino T, Komatsu Y, Isayama H, et al. Ulinastatin for pancreatitis after endoscopic retrograde cholangiopancreatography: a randomized, controlled trial. Clin Gastroenterol Hepatol. 2005;3:376-383.
15. Chen H, He MY, Li YM. Treatment of patients with severe sepsis using ulinastatin and thymosin alpha1: a prospective, randomized, controlled pilot study. Chin Med J (Engl). 2009;122:883-888.
16. Okuhama Y, Shiraishi M, Higa T, et al. Protective effects of ulinastatin against ischemia-reperfusion injury. J Surg Res. 1999;82:34-42.
17. Huang Y, Xie K, Zhang J, Dang Y, Qiong Z. Prospective clinical and experimental studies on the cardioprotective effect of ulinastatin following severe burns. Burns. 2008;34:674-680.
18. Gao C, Huan J, Li W, Tang J. Protective effects of ulinastatin on pancreatic and renal damage in rats following early scald injury. Burns. 200135:547-552.
19. Kümpers P, van Meurs M, David S, et al. Time course of angiopoietin-2 release during experimental human endotoxemia and sepsis. Crit Care. 2009;13:R64.
20. Hegde A, Zhang H, Moochhala SM, Bhatia M. Neurokinin-1 receptor antagonist treatment protects mice against lung injury in polymicrobial sepsis. J Leukoc Biol. 2007;82:678-685.
21. Wang YH, Gorvel JP, Chu YT, Wu JJ, Lei HY. Helicobacter pylori impairs murine dendritic cell responses to infection. PLoS One. 2010; 5:e10844.
22. Zhang X, Munegowda MA, Yuan J, Wei Y, Xiang J. Optimal TLR9 signal converts tolerogenic CD4-8-DCs into immunogenic ones capable of stimulating antitumor immunity via activating CD4+ Th1/Th17 and NK cell responses. J Leukoc Biol. 2010;88:393-403.
23. Burt BM, Plitas G, Nguyen HM, Stableford JA, Bamboat ZM, Dematteo RP. Circulating HLA-DR(+) natural killer cells have potent lytic ability and weak antigen-presenting cell function. Hum Immunol. 2008;69:469-474.
24. Hu J, Winqvist O, Flores-Morales A, Wikström AC, Norstedt G. SOCS2 influences LPS induced human monocyte-derived dendritic cell maturation. PLoS One. 2009;4:e7178.
25. Gomard T, Michaud HA, Tempé D, Thiolon K, Pelegrin M, Piechaczyk M. An NF-kappaB-dependent role for JunB in the induction of proinflammatory cytokines in LPS-activated bone marrow-derived dendritic cells. PLoS One. 2010;5:e9585.
26. Yanaba K, Bouaziz JD, Matsushita T, Tsubata T, Tedder TF. The development and function of regulatory B cells expressing IL-10 (B10 cells) requires antigen receptor diversity and TLR signals. J Immunol. 2009;182:7459-7472.
27. Lu YC, Kim I, Lye E, et al. Differential role for c-Rel and C/EBPbeta/delta in TLR-mediated induction of proinflammatory cytokines. J Immunol. 2009;182:7212-7221.
28. Young CS, Palma JM, Mosher BD, et al. Hepatic ischemia/reperfusion injury in P-selectin and intercellular adhesion molecule-1 double-mutant mice. Am Surg. 2001;67:737-744.